FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Eby

Research Profile

Chemicals & Drugs

Occupations

Pharmacogenetics

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Charles Eby
Warfarin pharmacogenetics: does more accurate dosing benefit patients?
Michael Avidan; Beth Burnside; Ralph Damiano; Charles Eby; Laureen Hill; Eric Jacobsohn; Lee P Skrupky; Jennifer R Smith; Heidi Tymkew; George J Despotis
The occurrence of antibodies to heparin-platelet factor 4 in cardiac and thoracic surgical patients receiving desirudin or heparin for postoperative venous thrombosis prophylaxis.
Cristi R King; Elena Deych; Paul E Milligan; Charles Eby; Petra Lenzini; Gloria Grice; Rhonda Porche-Sorbet; Paul M Ridker; Brian F Gage
Gamma-glutamyl carboxylase and its influence on warfarin dose.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Eby (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Charles Eby
Warfarin pharmacogenetics: does more accurate dosing benefit patients?
Seminars in thrombosis and hemostasis 2012;38(7):661-6.
2011: Michael Avidan; Beth Burnside; Ralph Damiano; Charles Eby; Laureen Hill; Eric Jacobsohn; Lee P Skrupky; Jennifer R Smith; Heidi Tymkew; George J Despotis
The occurrence of antibodies to heparin-platelet factor 4 in cardiac and thoracic surgical patients receiving desirudin or heparin for postoperative venous thrombosis prophylaxis.
Thrombosis research 2011;128(6):524-9.
2010: Cristi R King; Elena Deych; Paul E Milligan; Charles Eby; Petra Lenzini; Gloria Grice; Rhonda Porche-Sorbet; Paul M Ridker; Brian F Gage
Gamma-glutamyl carboxylase and its influence on warfarin dose.
Thrombosis and haemostasis 2010;104(4):750-4.
2010: Peter Weiser; Fei F Shih; Rhonda Porche-Sorbet; Charles Eby
Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010;16(3):251-60.
2009: George J Despotis; Michael Avidan; Charles Eby
Prediction and management of bleeding in cardiac surgery.
Journal of thrombosis and haemostasis : JTH 2009;7 Suppl 1():111-7.
2009: Charles Eby
Antiphospholipid syndrome review.
Clinics in laboratory medicine 2009;29(2):305-19.
2008: G R Grice; Paul E Milligan; Charles Eby; Brian F Gage
Pharmacogenetic dose refinement prevents warfarin overdose in a patient who is highly warfarin-sensitive.
Journal of thrombosis and haemostasis : JTH 2008;6(1):207-9.
2007: Petra A Lenzini; Gloria R Grice; Paul E Milligan; Susan K Gatchel; Elena Deych; Charles Eby; R Stephen J Burnett; John C Clohisy; Robert L Barrack; Brian F Gage
Optimal initial dose adjustment of warfarin in orthopedic patients.
The Annals of pharmacotherapy 2007;41(11):1798-804.
2007: Eric A Millican; Petra A Lenzini; Paul E Milligan; Leonard Grosso; Charles Eby; Elena Deych; Gloria Grice; John C Clohisy; Robert L Barrack; R Stephen J Burnett; Deepak Voora; Susan K Gatchel; Amy Tiemeier; Brian F Gage
Genetic-based dosing in orthopedic patients beginning warfarin therapy.
Blood 2007;110(5):1511-5.
2007: Priya K Gopalan; John C Clohisy; Amanda F Cashen; Charles Eby
Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency. A case report.
The Journal of bone and joint surgery. American volume 2007;89(2):389-91.
2005: Deepak Voora; howard mcleod; Charles Eby; Brian F Gage
The pharmacogenetics of coumarin therapy.
Pharmacogenomics 2005;6(5):503-13.
2005: Mark J Rieder; Alexander P Reiner; Brian F Gage; Deborah A Nickerson; Charles Eby; howard mcleod; David K Blough; Kenneth E Thummel; David L Veenstra; Allan E Rettie
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.
The New England journal of medicine 2005;352(22):2285-93.
2005: Deepak Voora; Charles Eby; Mark W Linder; Paul E Milligan; Bonny Bukaveckas; howard mcleod; William J Maloney; John C Clohisy; R Stephen J Burnett; Leonard Grosso; Susan K Gatchel; Brian F Gage
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.
Thrombosis and haemostasis 2005;93(4):700-5.
2004: Lawrence T Goodnough; Douglas M Lublin; Lini Zhang; George J Despotis; Charles Eby
Transfusion medicine service policies for recombinant factor VIIa administration.
Transfusion 2004;44(9):1325-31.
2004: Deepak Voora; howard mcleod; Charles Eby; Brian F Gage
Use of pharmacogenetics to guide warfarin therapy.
Drugs of today (Barcelona, Spain : 1998) 2004;40(3):247-57.
2004: Brian F Gage; Charles Eby
The genetics of vitamin K antagonists.
The pharmacogenomics journal 2004;4(4):224-5.
2004: Brian F Gage; Charles Eby; Paul E Milligan; Gerald A Banet; Jill R Duncan; howard mcleod
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.
Thrombosis and haemostasis 2004;91(1):87-94.
2003: Brian F Gage; Charles Eby
Pharmacogenetics and anticoagulant therapy.
Journal of thrombosis and thrombolysis 2003;16(1-2):73-8.